Skip to main content
Erschienen in: memo - Magazine of European Medical Oncology 1/2021

01.03.2021 | editorial

Paraprotein-associated diseases: a complex relationship between monoclonal gammopathy of unknown significance and severe organ damage

verfasst von: Hermine Agis, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

In this special issue we want to introduce new insights into a complex relationship between monoclonal gammopathy of unknown significance (MGUS) [1, 2], monoclonal gammopathy of renal significance (MGRS) [3], immunoglobulin light chain amyloidosis (AL) [4] and monoclonal gammopathy with clinical significance (MGCS) [5]. All of them are categorized as M‑protein related diseases. …
Literatur
3.
Zurück zum Zitat Leung N, Bridoux F, Batuman V, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019;15(1):45–59. https://doi.org/10.1038/s41581-018-0077-4. Erratum in: Nat Rev Nephrol. 2019;15(2):121.CrossRefPubMed Leung N, Bridoux F, Batuman V, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019;15(1):45–59. https://​doi.​org/​10.​1038/​s41581-018-0077-4. Erratum in: Nat Rev Nephrol. 2019;15(2):121.CrossRefPubMed
Metadaten
Titel
Paraprotein-associated diseases: a complex relationship between monoclonal gammopathy of unknown significance and severe organ damage
verfasst von
Hermine Agis, MD
Publikationsdatum
01.03.2021
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2021
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-021-00687-4

Weitere Artikel der Ausgabe 1/2021

memo - Magazine of European Medical Oncology 1/2021 Zur Ausgabe